Primary and preschool immunisation in Grampian: progress and the 1990 contract.

Ritchie, Lewis D; Bisset, Ann F; Russell, Daphne; Leslie, V.; Thomson, Irene

doi:10.1136/bmj.304.6830.816

Cited by 32 publications

(28 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kouides et al (1998) found that immunization rates rose 5.9 percent compared to a control group when PCPs received an additional ten or twenty percent payment per shot for each immunization made over target rates. Ritchie et al (1992) studied the effects of a lump sum payment received if a PCP immunized seventy percent of the eligible pre-school population. However, according to their study, the target payment intervention did not have a significant impact on immunization rates.…”

Section: Performance-based Payment Systemsmentioning

confidence: 99%

Provider Payment Methods and Incentives

Ellis¹,

Martins²,

Miller³

2017

International Encyclopedia of Public Health

View full text Add to dashboard Cite

Diverse provider payment systems create incentives that affect the quantity and quality of health care services provided. Payments can be based on provider characteristics, which tend to minimize incentives for quality and quantity. Or payments can be based on quantities of services provided and patient characteristics, which provide stronger incentives for quality and quantity. Payments methods using both broader bundles of services and larger numbers of payment categories are growing in prevalence. The recent innovation of performance-based payment attempts to target payments on key patient attributes so as to improve incentives, better manage patients, and control costs.

show abstract

Section: Performance-based Payment Systemsmentioning

confidence: 99%

Provider Payment Methods and Incentives

Ellis¹,

Martins²,

Miller³

2017

International Encyclopedia of Public Health

View full text Add to dashboard Cite

show abstract

“…86,94,146,239 Thirteen studies were not included in the review because of limited execution. 69,81,139,194,211,213,218,220,[231][232][233]237,238 Details regarding the 14 qualifying studies are provided at the website: http://web.health.gov/communityguide. Qualifying studies presented data regarding seven intervention arms evaluating assessment and feedback only and nine intervention arms evaluating assessment and feedback used as a part of a multicomponent intervention.…”

Section: Assessment and Feedback For Vaccination Providersmentioning

confidence: 99%

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22Some of this material was published previously in: Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev 1999;20:96–142.

Briss

Rodewald

Hinman

et al. 2000

American Journal of Preventive Medicine

469

103

View full text Add to dashboard Cite

Background: This paper presents the results of systematic reviews of the effectiveness, applicability, other effects, economic impact, and barriers to use of selected population-based interventions intended to improve vaccination coverage. The related systematic reviews are linked by a common conceptual approach. These reviews form the basis for recommendations by the Task Force on Community Preventive Services (the Task Force) regarding the use of these selected interventions. The Task Force recommendations are presented on pp. 92-96 of this issue. Medical Subject Headings (MeSH):vaccine-preventable diseases, vaccination coverage, community health services, decision-making, evidence-based medicine, systematic reviews, population-based interventions, practice guidelines, preventive health services, public health practice, task force. Introduction V accine-preventable diseases among children, adolescents, and adults represent major continuing causes of morbidity and mortality in the United States. During the latter half of the twentieth century, the success of childhood vaccination programs in the United States has led to a Ͼ95 % decline in most vaccine-preventable diseases of childhood. However, Ͼ400,000 cases of illness and Ͼ30,000 deaths caused by vaccine-preventable diseases still occur each year 1 (CDC unpublished data).Diphtheria, invasive Haemophilus influenzae type b (Hib) disease, measles, poliomyelitis, rubella, tetanus, mumps, varicella, and pertussis are typically referred to as vaccine-preventable diseases of childhood. Vaccinations primarily indicated for adults include influenza, pneumococcal, and hepatitis B. However, during the 1990s, the distinction between childhood and adult vaccine-preventable diseases became less clear. Many childhood vaccine-preventable infections, including measles and pertussis, are found increasingly among adults, 2,3 and hepatitis B vaccinations are now routinely recommended for infants and adolescents. Table 1 outlines universally recommended (i.e., vaccinations recommended for most or all persons in certain age groups) vaccinations for children, adolescents, and older adults.In children, Ͼ50,000 cases of varicella occur each year, making that disease the most common vaccinepreventable disease among children 4 ; in adults, influenza, pneumococcal disease, and hepatitis B are all still common vaccine-preventable diseases, with hundreds of thousands of cases occurring each year.5 Mortality attributable to vaccine-preventable diseases is still substantial. Each year, approximately 500 persons in the United States die of childhood vaccine-preventable diseases, and Ͼ30,000 adults die of influenza, pneumococcal infections, and hepatitis B.1 Influenza, which accounts for an average of 20,000 deaths/year, is usually the largest killer. 5The effectiveness of universally recommended vaccinations in preventing disease for adults, adolescents, and children is well-established. 6 -14 In addition to protecting individuals from diseases passed from person to person contact, vaccinat...

show abstract

“…The first of these studies [20] evaluated outcomes after the 1990 contract that included targeted payments for higher immunization rates, and the latter two studies evaluated diabetes [25] or multiple measures [26 ] after the $3.2 billion pay-for-performance contract of 2004 that rewarded quality targets in managing 10 chronic diseases. Control groups were not possible in these studies.…”

Section: Studies Using Designs Other Than Randomized Controlled Trialsmentioning

confidence: 99%

“…Three studies evaluated outcomes before and after new general practitioner contracts in the United Kingdom [20,25,26 ] (Table 2). The first of these studies [20] evaluated outcomes after the 1990 contract that included targeted payments for higher immunization rates, and the latter two studies evaluated diabetes [25] or multiple measures [26 ] after the $3.2 billion pay-for-performance contract of 2004 that rewarded quality targets in managing 10 chronic diseases.…”

Section: Studies Using Designs Other Than Randomized Controlled Trialsmentioning

confidence: 99%

Does pay-for-performance influence the quality of care?

Schatz

2008

Current Opinion in Allergy &Amp; Clinical Immunology

View full text Add to dashboard Cite

The data reviewed in this article suggest that pay-for-performance programmes can improve markers of quality, though not always. Even when studies suggest positive effects, the designs often do not permit assurance that the effects are due to the incentives as compared with other factors. More and better-designed studies are needed to determine the actual effectiveness of incentives themselves isolated from other factors, circumstances that promote effectiveness, effectiveness relative to other strategies, and cost-effectiveness.

show abstract

Primary and preschool immunisation in Grampian: progress and the 1990 contract.

Cited by 32 publications

References 10 publications

Provider Payment Methods and Incentives

Provider Payment Methods and Incentives

Does pay-for-performance influence the quality of care?

Contact Info

Product

Resources

About